DISCOVERY AND LICENSE AGREEMENT Between RAYZEBIO, INC. And BLAZE BIOSCIENCE, INC. dated: February 22, 2021Discovery and License Agreement • February 11th, 2022 • RayzeBio, Inc. • Pharmaceutical preparations • New York
This Discovery and License Agreement (the “Agreement”) is made and entered into as of February 22, 2021 (the “Effective Date”) by and between RayzeBio, Inc., a Delaware corporation, having its principal place of business at 9880 Campus Point Dr., Suite 410, San Diego, CA 92121 (“Rayze”), and Blaze Bioscience, Inc., a Delaware corporation, having its principal place of business at 530 Fairview Avenue North, Suite 1400, Seattle, WA 98109 (“Blaze”). Rayze and Blaze are sometimes referred to individually as a “Party” and collectively as the “Parties.”
